TrialPain research & management2018

Intranasal Pharmacokinetics of Morphine ARER, a Novel Abuse-Deterrent Formulation: Results from a Randomized, Double-Blind, Four-Way Crossover Study in Nondependent, Opioid-Experienced Subjects.

Lynn R Webster et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.